Genomics Integration Into Nephrology Practice.

ABSTRACT:

Rationale & objective

The etiology of kidney disease remains unknown in many individuals with chronic kidney disease (CKD). We created the Mayo Clinic Nephrology Genomics Clinic to improve our ability to integrate genomic and clinical data to identify the etiology of unexplained CKD.

Study design

Retrospective study.

Setting & participants

An essential component of our program is the Nephrology Genomics Board which consists of nephrologists, geneticists, pathologists, translational omics scientists, and trainees who interpret the patient's clinical and genetic data. Since September 2016, the Board has reviewed 163 cases (15 cystic, 100 glomerular, 6 congenital anomalies of kidney and urinary tract (CAKUT), 20 stones, 15 tubulointerstitial, and 13 other).

Analytical

SUBMITTER: Pinto E Vairo F 

PROVIDER: S-EPMC8551494 | biostudies-literature | 2021 Sep-Oct

REPOSITORIES: biostudies-literature